Bio Essence Corp financial data

Symbol
BIOE on OTC
Industry
Pharmaceutical Preparations
Location
2955 Main Street, Ste 300, Irvine, CA
State of incorporation
CA
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 23.6 % +136%
Quick Ratio 6.07 % -5.3%
Debt-to-equity -158 % +21.6%
Return On Equity 57 % +12.9%
Return On Assets -97.9 % -97.5%
Operating Margin -62.7 % +23.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38M shares 0%
Common Stock, Shares, Outstanding 38M shares 0%
Entity Public Float 26.8M USD
Common Stock, Value, Issued 3.8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 38M shares +11.9%
Weighted Average Number of Shares Outstanding, Diluted 38M shares +9.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 135K USD -13.5%
Cost of Revenue 53.7K USD -60.4%
General and Administrative Expense 677K USD +95.8%
Operating Income (Loss) -459K USD -32.9%
Nonoperating Income (Expense) -1.05M USD -4600%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.56M USD -288%
Income Tax Expense (Benefit) 800 USD -50%
Net Income (Loss) Attributable to Parent -1.31M USD -34.7%
Earnings Per Share, Basic -0.03 USD/shares 0%
Earnings Per Share, Diluted -0.03 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.37K USD +1103%
Accounts Receivable, after Allowance for Credit Loss, Current 5.12K USD -85.4%
Inventory, Net 143K USD -20.9%
Assets, Current 281K USD -6.44%
Property, Plant and Equipment, Net 3.69K USD -98.5%
Operating Lease, Right-of-Use Asset 1.18M USD +20.8%
Intangible Assets, Net (Excluding Goodwill) 332 USD -41.4%
Other Assets, Noncurrent 332 USD -100%
Assets 281K USD -89.8%
Accounts Payable, Current 17.7K USD +42.4%
Accrued Liabilities, Current 3.3K USD -51.1%
Liabilities, Current 2.8M USD +14.4%
Operating Lease, Liability, Noncurrent 392K USD -58.2%
Other Liabilities, Noncurrent 447K USD -54.9%
Liabilities 3.25M USD -26.4%
Retained Earnings (Accumulated Deficit) -10.4M USD -14.3%
Stockholders' Equity Attributable to Parent -2.97M USD -78.8%
Liabilities and Equity 281K USD -89.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -172K USD +25.9%
Net Cash Provided by (Used in) Financing Activities 172K USD -23.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 38M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 23 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.37K USD +1103%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.7K USD -20.2%
Deferred Tax Assets, Valuation Allowance 659K USD +3.59%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 658K USD +3.59%
Operating Lease, Liability 1.39M USD
Depreciation 2.37K USD -84.4%
Lessee, Operating Lease, Liability, to be Paid 1.56M USD
Property, Plant and Equipment, Gross 56.5K USD -6.01%
Operating Lease, Liability, Current 1.07M USD +116%
Lessee, Operating Lease, Liability, to be Paid, Year Two 588K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 571K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 3.2K USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 125K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 400K USD
Current Income Tax Expense (Benefit) 3.2K USD 0%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 7.48M USD 0%
Amortization of Intangible Assets 235 USD 0%
Depreciation, Depletion and Amortization 497 USD -80%
Interest Expense 542 USD -2.17%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%